x

Search for a clinical trial

* (*) mandatory field

A Phase I, Multi-center, Open-label Study of LEE011 in Patients With Malignant Rhabdoid Tumors and Neuroblastoma - FR

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Novartis pharmaceutical corporation
  • Website
    • Phase : I
  • Principal investigator of clinical trial

  • Dr Franck BOURDEAUT
  • Département d'Oncologie pédiatrique, adolescents et jeunes adultes
  • CLCC Institut Curie
  • 26 rue d'Ulm
  • 75248 PARIS CEDEX 05
  • FRANCE
  • More information
  • Phone  : 33 (0)1 44 32 45 55/50
  • Fax  : 33 (0)1 53 10 40 05
  • Website
Last update: December 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.